Needham, Massachusetts
United States
26
2025-12-25
The entities that hold a legal rights for patent applications filed by inventor Liu Kun:
Kun Liu from Needham, US has applied for patents for these inventions. The list has both pending applications and granted patents:
SUBSTITUTED AMINO TRIAZOLOPYRIMIDINE AND AMINO TRIAZOLOPYRAZINE ADENOSINE RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE
#2 | 2023-02-237-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
#3 | 2022-07-149-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
#4 | 2022-02-10SUBSTITUTED AMINO TRIAZOLOPYRIMIDINE AND AMINO TRIAZOLOPYRAZINE ADENOSINE RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE
#5 | 2021-06-17Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
#6 | 2021-04-159-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
#7 | 2020-09-17Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
#8 | 2020-09-03Substituted cyclobutylbenzene compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
#9 | 2020-07-23Substituted nā²-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
#10 | 2020-07-23Substituted imidazopyridine compounds as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan-2,3-dioxygenase
#11 | 2020-07-09Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
#12 | 2020-04-02Substituted Nā²-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitors
#13 | 2020-03-26Substituted sulfoximine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
#14 | 2019-09-26Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
#15 | 2019-09-12Substituted indazole compounds as RORgammaT inhibitors and uses thereof
#16 | 2019-06-27Heteroaryl substituted benzoic acids as RORgammaT inhibitors and uses thereof
#17 | 2019-05-16Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
#18 | 2018-12-20Compounds as indoleamine 2,3-dioxygenase inhibitors
#19 | 2018-11-01Substituted indazole compounds as RORgammaT inhibitors and uses thereof
#20 | 2018-10-25Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereof
#21 | 2018-02-01Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
#22 | 2017-08-31Diazine-fused amidines as BACE inhibitors, compositions, and their use
#23 | 2016-07-07Glycosidase inhibitors and uses thereof
#24 | 2015-07-02Mineralocorticoid receptor antagonists
#25 | 2015-06-04Permeable glycosidase inhibitors and uses thereof
#26 | 2014-09-11Mineralocorticoid receptor antagonists
905159 ā